A recent study suggests that Paxlovid is ineffective at treating symptoms in people with mild illness or those who have been ...
The FDA's accelerated approval program is meant to give patients early access to promising drugs, but a new study found most ...
AstraZeneca has secured the FDA’s green light for Voydeya, a first-in-class, oral, Factor D inhibitor developed as an add-on ...
MassDevice has an exclusive interview with Orthobond CEO David Nichols, who says the technology has potential beyond spine ...
The Food and Drug Administration granted a full approval to Elahere for the treatment of certain patients with platinum-resistant gynecologic cancers. The Food and Drug Administration (FDA) granted a ...
Merck MRK announced that the FDA has granted approval to its novel activin signaling inhibitor, sotatercept, for treating adult patients with pulmonary arterial hypertension (PAH, WHO Group 1).
The Food and Drug Administration said Friday it granted full approval to AbbVie and ImmunoGen’s cancer drug ...
After sustaining a regulatory defeat in insomnia, Vanda Pharmaceuticals on Tuesday won the FDA’s approval for its atypical ...
Credit: AbbVie. Conversion to regular approval from accelerated approval was based on data from the confirmatory phase 3 MIRASOL trial. Mirvetuximab soravtansine achieved a statistically ...
Medtronic plc MDT recently secured the FDA’s approval for the Evolut FX+ transcatheter ... Early Commercial Experience is planned for spring 2024, with a full product launch expected in summer ...